Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).Brachytherapy is the placement of radioactive sources in or ...

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.The new prediction method comprises the length of time it takes for PSA (prostate-specific antigen) to double, Gleason score (a numeric indicator of prostate cancer ...

July 2, 2009 - Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis (the spread of the cancer to other parts of the body).

"I am sending out this note to inform you that I have been diagnosed with prostate cancer, and will be undergoing surgery Monday, June 8, at Fairview Ridges Hospital in Burnsville."

VANCOUVER, B.C. - The B.C. Human Rights Tribunal has been ordered to reconsider whether it's discriminatory to make men pay for prostate cancer screening tests while providing free pap exams and mammograms to women.

A PIONEERING prostate cancer treatment is more successful than radiotherapy or surgery, British scientists say.

THURSDAY, July 2 (HealthDay News) -- A second gene linked to inherited testicular germ-cell cancer has been identified by scientists at the U.S.

One of the most controversial issues in men's health is whether men should routinely have a blood test for prostate-specific antigen (PSA) to screen for prostate cancer. Some experts argue that PSA testing saves lives by helping detect this common form of cancer early. Others say it triggers unnecessary treatment that disrupts many more lives than it saves.

THURSDAY, July 2 (HealthDay News) -- A second gene linked to inherited testicular germ-cell cancer has been identified by scientists at the U.S. National Institutes of Health.

A just published Review in the publication "Expert Opinion on Investigational Drugs", Volume 18, Issue 7 2009, confirms the previous published information on PROSTVAC(TM). This is the most comprehensive and updated Review on PROSTVAC(TM) so far.

A pioneering treatment for the UK's most common male cancer is more successful than surgery or radiotherapy according to a landmark study by British scientists.

An Experimental cancer therapy for prostate cancer may be able to treat men without surgery and offer fewer side effects according to the results of a UK study published in the British Journal of Cancer.

In a perverse twist of medical fate, Farrah Fawcett has become the poster girl for anal cancer, a rare disease often linked to a sexually transmitted virus.

Dr. Gary D. Kao testified Monday about botched prostate cancer treatment he gave to patients at a Veterans Affairs hospital run by the University of Pennsylvania.

The cancer labs of Elizabeth Blackburn, Chad Mirkin, and Elaine Mardis and Rick Wilson get shout-outs in three US News & World Report articles. Blackburn is looking to exploit cancer cells' use of telomerase to engineer a way to kill the cells; she is also intrigued by lifestyle influences, such as exercise and nutrition, on telomerase levels.

Men with early prostate cancer could be treated with soundwave technology instead of surgery, according to new research. The experimental therapy also leads to fewer side-effects, according to the study on 172 men whose cancer had not spread beyond their prostate.

The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate, Lung, Colorectal and Ovarian Ca

VANCOUVER, B.C. - The B.C. Human Rights Tribunal has been ordered to reconsider whether it's discriminatory to make men pay for prostate cancer screening tests while providing free pap exams and mammograms to women.

Doctors are hailing a breakthrough in the fight against prostate cancer after a British patient was successfully treated for the illness by a pioneering surgical robot.

Spring Lake's Jim Walters is one of the lucky ones.